164 related articles for article (PubMed ID: 30925450)
1. A more accurate method to interpret lactate dehydrogenase (LDH) isoenzymes' results in patients with uterine masses.
Di Cello A; Borelli M; Marra ML; Franzon M; D'Alessandro P; Di Carlo C; Venturella R; Zullo F
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():143-147. PubMed ID: 30925450
[TBL] [Abstract][Full Text] [Related]
2. Specificity of the lactate dehydrogenase isoenzyme index as a preoperative screen for uterine sarcoma before myomectomy.
Spivack LE; Glantz JC; Lennon C; Bhagavath B
Fertil Steril; 2021 Jan; 115(1):174-179. PubMed ID: 33070962
[TBL] [Abstract][Full Text] [Related]
3. Increased LDH5/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: a case report.
Mollo A; Raffone A; Travaglino A; Di Cello A; Saccone G; Zullo F; De Placido G
BMC Womens Health; 2018 Oct; 18(1):169. PubMed ID: 30340636
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.
Song KJ; Yu XN; Lv T; Chen YL; Diao YC; Liu SL; Wang YK; Yao Q
Medicine (Baltimore); 2018 Apr; 97(14):e0268. PubMed ID: 29620641
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.
Goto A; Takeuchi S; Sugimura K; Maruo T
Int J Gynecol Cancer; 2002; 12(4):354-61. PubMed ID: 12144683
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma.
Nishigaya Y; Kobayashi Y; Matsuzawa Y; Hasegawa K; Fukasawa I; Watanabe Y; Tokunaga H; Yaegashi N; Iwashita M
J Obstet Gynaecol Res; 2019 Jan; 45(1):189-194. PubMed ID: 30152048
[TBL] [Abstract][Full Text] [Related]
8. Analysis of uterine corporeal mesenchymal tumors occurring after menopause.
Ishidera Y; Yoshida H; Oi Y; Katayama K; Miyagi E; Hayashi H; Shigeta H
BMC Womens Health; 2019 Jan; 19(1):13. PubMed ID: 30658711
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate dehydrogenase profile as a retrospective indicator of uterine preparedness for labor: a prospective, observational study.
Neal JL; Lowe NK; Corwin EJ
BMC Pregnancy Childbirth; 2013 Jun; 13():128. PubMed ID: 23759027
[TBL] [Abstract][Full Text] [Related]
10. The heterogeneity of LDH isoenzyme patterns of human uterine sarcomas and cultured sarcoma cell lines.
Nelson KG; Siegfried JM; Siegal GP; Becker R; Walton LA; Kaufman DG
Am J Pathol; 1984 Jul; 116(1):85-93. PubMed ID: 6742109
[TBL] [Abstract][Full Text] [Related]
11. Circulating Protein Biomarkers to Differentiate Uterine Sarcomas from Leiomyomas.
Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
13. The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.
Bien E; Rapala M; Krawczyk M; Balcerska A
J Cancer Res Clin Oncol; 2010 Feb; 136(2):293-305. PubMed ID: 19693535
[TBL] [Abstract][Full Text] [Related]
14. Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?
Mazzotta S; Guerranti R; Gozzetti A; Bucalossi A; Bocchia M; Sammassimo S; Petralia S; Ogueli GI; Lauria F
Hematology; 2006 Aug; 11(4):239-44. PubMed ID: 17178662
[TBL] [Abstract][Full Text] [Related]
15. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract][Full Text] [Related]
16. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma.
Kawamura N; Ichimura T; Ito F; Shibata S; Takahashi K; Tsujimura A; Ishiko O; Haba T; Wakasa K; Ogita S
Cancer; 2002 Mar; 94(6):1713-20. PubMed ID: 11920533
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma.
Maeno M; Mizutani T; Tsuyoshi H; Yamada S; Ishikane S; Kawabe S; Nishimura K; Yamada M; Miyamoto K; Yoshida Y
Endocr J; 2020 Jan; 67(1):91-94. PubMed ID: 31534059
[TBL] [Abstract][Full Text] [Related]
18. Effect of chlorocamphene on the isoenzyme spectrum of lactate dehydrogenase in rat serum and liver.
Kuz'minskaya UA; Alekhina SM
Environ Health Perspect; 1976 Feb; 13():127-32. PubMed ID: 1269500
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Biomarkers in Myoma Patients: A Prospective Study Investigating the Role of LDH, CA 125, and IGF-1 after Uterus-Preserving Surgical Therapy.
Jacob M; Richter R; Sehouli J; David M
Gynecol Obstet Invest; 2021; 86(1-2):100-107. PubMed ID: 33582665
[TBL] [Abstract][Full Text] [Related]
20. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
